Metraipolis › archive › dc_7b82217fbcbd

TCR-Based Antigen-Specific Therapy for Type 1 Diabetes Mellitus: From Editing Autoreactive Clones to Tolerance Induction — Europe PMC PMID:41373714

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41373714
DOI
10.3390/ijms262311563
License (as archived)
solo-consultazione
Archived
2026-11-08T04:44:07.615Z
SHA-256 of the archived text
7ca4c1ab6d66a66c58cdf219f7b750750edb7c12235db1e9e3f2abc941f0e8db
Stable URL of this page
https://metraipolis.com/documento/dc_7b82217fbcbd

How to cite

TCR-Based Antigen-Specific Therapy for Type 1 Diabetes Mellitus: From Editing Autoreactive Clones to Tolerance Induction — Europe PMC PMID:41373714 — Europe PMC (en), https://europepmc.org/article/MED/41373714 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7b82217fbcbd (Metraipolis archive dc_7b82217fbcbd, sha256 7ca4c1ab6d66a66c58cdf219f7b750750edb7c12235db1e9e3f2abc941f0e8db)
BibTeX
@misc{dc7b82217fbcbd,
  title = {TCR-Based Antigen-Specific Therapy for Type 1 Diabetes Mellitus: From Editing Autoreactive Clones to Tolerance Induction — Europe PMC PMID:41373714},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41373714},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7b82217fbcbd; sha256 7ca4c1ab6d66a66c58cdf219f7b750750edb7c12235db1e9e3f2abc941f0e8db},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41373714. Agents can read the archived copy with the MCP tool read_document.